31,695 Shares in Amicus Therapeutics, Inc. (NASDAQ:FOLD) Purchased by Aigen Investment Management LP
Aigen Investment Management LP bought a new position in shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD – Free Report) during the third quarter, Holdings Channel reports. The fund bought 31,695 shares of the biopharmaceutical company’s stock, valued at approximately $385,000. A number of other institutional investors also recently bought and sold shares of the company. Vanguard […]
More Stories
Okta (NASDAQ:OKTA) Price Target Cut to $130.00 by Analysts at Mizuho
Okta (NASDAQ:OKTA – Free Report) had its price target cut by Mizuho from $135.00 to $130.00 in a research report...
Stifel Nicolaus Issues Positive Forecast for Okta (NASDAQ:OKTA) Stock Price
Okta (NASDAQ:OKTA – Free Report) had its price objective lifted by Stifel Nicolaus from $120.00 to $130.00 in a research...
NuScale Power (NYSE:SMR) Trading Up 10.1% After Analyst Upgrade
Shares of NuScale Power Co. (NYSE:SMR – Get Free Report) were up 10.1% during trading on Tuesday after CLSA raised...
Toy Stocks To Follow Now – May 27th
GameStop, Walmart, Costco Wholesale, Target, Kroger, Take-Two Interactive Software, and Burlington Stores are the seven Toy stocks to watch today,...
Oklo (NYSE:OKLO) Shares Up 5.9% After Analyst Upgrade
Oklo Inc. (NYSE:OKLO – Get Free Report)’s share price rose 5.9% on Tuesday after CLSA raised their price target on...
Piper Sandler Lowers Prothena (NASDAQ:PRTA) Price Target to $81.00
Prothena (NASDAQ:PRTA – Get Free Report) had its target price cut by research analysts at Piper Sandler from $110.00 to...